Hong Kong · Delayed Price · Currency is HKD CF PharmTech Statistics
Total Valuation
CF PharmTech has a market cap or net worth of HKD 2.46 billion. The enterprise value is 2.13 billion.
| Market Cap | 2.46B |
| Enterprise Value | 2.13B |
Important Dates
The next estimated earnings date is Tuesday, December 1, 2026.
| Earnings Date | Dec 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CF PharmTech has 406.36 million shares outstanding. The number of shares has increased by 7.21% in one year.
| Current Share Class | 296.61M |
| Shares Outstanding | 406.36M |
| Shares Change (YoY) | +7.21% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 10.11% |
| Float | 221.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.88 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.22 |
| EV / EBITDA | 29.17 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.21 |
| Quick Ratio | 2.80 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | -1.30 |
| Interest Coverage | -2.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -0.56% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 806,830 |
| Profits Per Employee | -12,544 |
| Employee Count | 625 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -17.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -84.27% |
| 50-Day Moving Average | 12.49 |
| 200-Day Moving Average | 22.40 |
| Relative Strength Index (RSI) | 23.10 |
| Average Volume (20 Days) | 3,757,248 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CF PharmTech had revenue of HKD 504.27 million and -7.84 million in losses. Loss per share was -0.02.
| Revenue | 504.27M |
| Gross Profit | 384.31M |
| Operating Income | -9.62M |
| Pretax Income | -25.28M |
| Net Income | -7.84M |
| EBITDA | 69.87M |
| EBIT | -9.62M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 576.65 million in cash and 245.12 million in debt, with a net cash position of 331.53 million or 0.82 per share.
| Cash & Cash Equivalents | 576.65M |
| Total Debt | 245.12M |
| Net Cash | 331.53M |
| Net Cash Per Share | 0.82 |
| Equity (Book Value) | 1.55B |
| Book Value Per Share | 3.77 |
| Working Capital | 614.05M |
Cash Flow
In the last 12 months, operating cash flow was -8.58 million and capital expenditures -179.86 million, giving a free cash flow of -188.44 million.
| Operating Cash Flow | -8.58M |
| Capital Expenditures | -179.86M |
| Depreciation & Amortization | 80.74M |
| Net Borrowing | 115.35M |
| Free Cash Flow | -188.44M |
| FCF Per Share | -0.46 |
Margins
Gross margin is 76.21%, with operating and profit margins of -1.91% and -1.55%.
| Gross Margin | 76.21% |
| Operating Margin | -1.91% |
| Pretax Margin | -5.01% |
| Profit Margin | -1.55% |
| EBITDA Margin | 13.86% |
| EBIT Margin | -1.91% |
| FCF Margin | n/a |
Dividends & Yields
CF PharmTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.21% |
| Shareholder Yield | -7.21% |
| Earnings Yield | -0.32% |
| FCF Yield | -7.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CF PharmTech has an Altman Z-Score of 15.87 and a Piotroski F-Score of 1.
| Altman Z-Score | 15.87 |
| Piotroski F-Score | 1 |